https://medicaex.com/prnewswire/exocobios-first-global-regenerative-aesthetic-exosome-summit/ 2022-08-17T02:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/08/ExoCoBio_s_First_Global_Regenerative_Aesthetic_Exosome_Summit-E3Xf9C.jpeg https://medicaex.com/prnewswire/kronos-bio-and-invivoscribe-partner-on-companion-diagnostic-for-use-with-entospletinib-kronos-bios-investigational-compound-being-developed-for-patients-with-aml/ 2022-08-16T21:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/08/Invivoscribe_Technologies_Inc_Kronos_Bio_Partnership-Mdpigq.jpeg https://medicaex.com/prnewswire/sirnaomics-develops-peptide-docking-vehicle-pdovtm-designed-for-an-enhanced-galnac-delivery-platform-for-novel-sirna-therapeutics/ 2022-08-16T20:00:31+00:00 https://medicaex.com/prnewswire/everest-medicines-enters-into-agreement-with-gilead-sciences-for-trodelvy-in-asia-territories/ 2022-08-16T12:00:26+00:00 https://medicaex.com/prnewswire/lunit-announces-financial-results-for-the-first-half-of-2022/ 2022-08-16T11:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/08/Lunit_CI_Logo-5lfSLo.jpeg https://medicaex.com/prnewswire/profitable-growth-continues-exyte-with-remarkable-6m-2022-results-and-uplifted-year-end-outlook/ 2022-08-16T09:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/08/Exyte_Logo-9FpBH2.jpeg https://medicaex.com/prnewswire/manulife-hong-kong-and-hong-kong-association-of-athletics-affiliates-form-partnership-to-establish-the-manulife-gba-hk-zhuhai-macao-bridge-half-marathon/ 2022-08-16T09:00:13+00:00 https://medicaex.com/wp-content/uploads/2022/08/DSC9085_high_res-pEpnMZ.jpeg https://medicaex.com/prnewswire/medalliance-selution-slr-receives-second-fda-ide-approval/ 2022-08-16T05:00:56+00:00 https://medicaex.com/wp-content/uploads/2022/08/MedAlliance_SELUTION-8YxtcN.jpeg https://medicaex.com/prnewswire/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner/ 2022-08-16T02:00:34+00:00 https://medicaex.com/wp-content/uploads/2022/08/VivoSight_1-l7huZf.jpeg https://medicaex.com/prnewswire/wuxi-atu-announces-licensing-agreement-with-janssen-for-tessa-technology/ 2022-08-16T02:00:24+00:00 https://medicaex.com/prnewswire/gannex-announces-first-subject-dosed-in-the-u-s-drug-drug-interaction-study-of-fxr-agonist-asc42-for-treatment-of-primary-biliary-cholangitis/ 2022-08-16T01:00:24+00:00 https://medicaex.com/prnewswire/lenstec-sbl-3-multifocal-intraocular-lens-for-cataract-surgery-approved-by-fda-for-sale-in-the-us/ 2022-08-16T00:00:05+00:00 https://medicaex.com/prnewswire/rokit-healthcare-to-enable-innovation-in-treatment-of-diabetes-foot-and-osteoarthritis-combining-ai-and-3d-bioprinting-on-google-cloud-2/ 2022-08-15T00:00:11+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_1-mYXSAz.jpeg https://medicaex.com/prnewswire/united-biopharmas-study-reveals-new-class-of-monoclonal-antibody-for-effective-relief-of-urticaria-symptoms-2/ 2022-08-12T13:00:44+00:00 https://medicaex.com/prnewswire/histoindex-stain-free-ai-dp-reveals-treatment-induced-zonal-regression-of-fibrosis-colocalized-with-reduction-in-steatosis-hepatocyte-ballooning-in-flight-fxr-nash-clinical-trial/ 2022-08-12T12:00:38+00:00 https://medicaex.com/prnewswire/seegene-reports-h1-2022-financial-results/ 2022-08-12T12:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/08/Seegene_logo_Logo-LgHcOc.jpeg https://medicaex.com/prnewswire/asieris-appoints-dr-badrinath-konety-to-scientific-advisory-board/ 2022-08-12T11:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/08/Dr__Badrinath_Konety-LmuWr2.jpeg https://medicaex.com/prnewswire/recbio-announces-phase-iii-clinical-trial-progress-of-recombinant-hpv-9-valent-vaccine/ 2022-08-12T10:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/08/Recbio_Logo-HfWhBx.jpeg https://medicaex.com/prnewswire/genesis-capital-invests-in-crux-biolabs-a-leading-bioanalytical-laboratory-to-the-clinical-trials-sector/ 2022-08-12T02:00:38+00:00 https://medicaex.com/prnewswire/top-organizations-lauded-with-prestigious-industry-recognition-by-frost-sullivan-for-best-in-class-performance/ 2022-08-11T13:00:10+00:00 https://medicaex.com/wp-content/uploads/2022/08/10th_VE_YouTube_Thumbnail__resized-DfWdPY.jpeg https://medicaex.com/prnewswire/st-pharm-presents-phase-1-clinical-trial-results-of-hiv-treatment-candidate-at-aids-2022/ 2022-08-11T12:00:50+00:00 https://medicaex.com/prnewswire/zepp-health-corp-to-report-second-quarter-2022-financial-results-on-august-25-2022/ 2022-08-11T12:00:12+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-regulatory-update-and-strategic-partnership-for-xerava-in-taiwan/ 2022-08-11T01:00:21+00:00 https://medicaex.com/prnewswire/deep-longevity-selected-by-kickstart-as-one-of-the-most-promising-start-ups-in-the-world-discussing-proof-of-concepts-with-big-insurance-and-health-and-wellbeing-companies/ 2022-08-10T15:00:10+00:00 https://medicaex.com/prnewswire/kintor-pharma-announces-completion-of-patient-enrollment-in-phase-ii-clinical-trial-of-kx-826-for-treatment-of-androgenetic-alopecia-in-the-us/ 2022-08-10T14:00:44+00:00 https://medicaex.com/prnewswire/nuralogix-researchers-announce-ai-models-that-can-predict-metabolic-risks/ 2022-08-10T13:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/08/NuraLogix_Corporation_NuraLogix_researchers_announce_AI_models_t-0Ejb3E.jpeg https://medicaex.com/prnewswire/ubiquitomes-liberty16-pro-ready-to-carve-up-next-covid-wave/ 2022-08-10T12:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/08/Libert16_Pro_Render_01-FKfSkE.jpeg https://medicaex.com/prnewswire/inmagene-and-hutchmed-announce-first-participants-in-global-phase-i-trial-of-img-004/ 2022-08-10T10:02:12+00:00 https://medicaex.com/prnewswire/kintor-pharma-announces-completion-of-subject-enrollment-and-dosing-in-phase-i-clinical-trial-of-ar-protacgt20029-in-china/ 2022-08-10T10:02:11+00:00 https://medicaex.com/prnewswire/onesight-essilorluxottica-foundation-announces-publication-of-new-article/ 2022-08-10T10:01:54+00:00 https://medicaex.com/wp-content/uploads/2022/08/Vision_Impact_Institute_Logo-YCkIO7.jpeg https://medicaex.com/prnewswire/frost-sullivan-institute-recognizes-samsung-biologics-with-the-2022-global-enlightened-growth-leadership-award-for-its-commitment-to-sustainable-growth/ 2022-08-10T10:01:54+00:00 https://medicaex.com/wp-content/uploads/2022/08/EGL_Web_banner_Samsung_Biologics-BhSGYq.jpeg https://medicaex.com/prnewswire/intron-developed-new-crispr-cas-technology-specific-for-bacteriophage-as-phagerus-platform/ 2022-08-10T10:01:53+00:00 https://medicaex.com/prnewswire/innovent-announces-phase-2-clinical-study-of-picankibart-ibi112-in-chinese-patients-with-moderate-to-severe-plaque-psoriasis-met-primary-endpoint/ 2022-08-10T10:01:53+00:00 https://medicaex.com/prnewswire/starpharma-signs-new-dep-agreement-with-msd/ 2022-08-10T10:01:52+00:00 https://medicaex.com/prnewswire/uassist-aligner-planning-assistance-service-available-for-orthodontists/ 2022-08-10T09:28:36+00:00 https://medicaex.com/wp-content/uploads/2022/08/ulab_Logo-hSEt1P.jpeg https://medicaex.com/prnewswire/xinhua-silk-road-e-chinas-wuxi-city-steps-up-biomedical-industry-development/ 2022-08-08T14:58:41+00:00 https://medicaex.com/wp-content/uploads/2022/08/image1-2oEZ4z.jpeg https://medicaex.com/prnewswire/immviras-brand-new-ohsv-product-mvr-c5252-targeting-malignant-glioma-obtained-fdas-orphan-drug-designation/ 2022-08-08T14:58:41+00:00 https://medicaex.com/wp-content/uploads/2022/08/image-mRZuFA.jpeg https://medicaex.com/prnewswire/pnas-published-preclinical-results-of-harbour-biomeds-next-generation-fully-human-heavy-chain-antibody-porustobart/ 2022-08-08T14:58:39+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_1-BXO1zd.jpeg https://medicaex.com/prnewswire/bgi-ranks-no-1-among-apac-and-china-life-science-corporations-for-seven-consecutive-years-2022-nature-index-annual-tables-revealed/ 2022-08-08T14:58:38+00:00 https://medicaex.com/wp-content/uploads/2022/08/Nature_Index_Asia_Pacific_Rankings_January_1_December_31_2021-E0W3fO.jpeg https://medicaex.com/prnewswire/point-of-care-ultrasound-certification-academy-to-host-world-conference/ 2022-08-08T13:58:37+00:00 https://medicaex.com/prnewswire/prominent-stanford-university-scientist-and-cellular-reprogramming-innovator-will-oversee-all-research-for-turn-bio/ 2022-08-08T13:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/08/Vittorio_Sebastiano_PhD-WEdawX.jpeg https://medicaex.com/prnewswire/amwell-applauded-by-frost-sullivan-for-its-comprehensive-digital-care-delivery-enablement-platform-converge/ 2022-08-08T13:00:03+00:00 https://medicaex.com/wp-content/uploads/2022/08/Amwell_Award-1KNHBD.jpeg https://medicaex.com/prnewswire/novavax-nuvaxovid-covid-19-vaccine-granted-provisional-registration-in-australia-for-use-in-adolescents-aged-12-through-17/ 2022-08-08T10:58:00+00:00 https://medicaex.com/wp-content/uploads/2022/08/Novavax_High_Res_Logo-TCh9Gh.jpeg https://medicaex.com/prnewswire/transcenta-announces-the-appointment-of-dr-caroline-germa-as-executive-vice-president-global-medicine-development-and-chief-medical-officer/ 2022-08-08T08:58:01+00:00 https://medicaex.com/prnewswire/innovent-announces-first-patient-dosed-in-phase-1-study-of-ibi324-vegf-a-ang-2-bispecific-antibody-in-patients-with-diabetic-macular-edema/ 2022-08-08T08:58:00+00:00 https://medicaex.com/prnewswire/taiwan-approves-the-first-autonomous-neurosurgical-navigation-robot-naotrac-from-brain-navi-biotechnology/ 2022-08-08T04:58:33+00:00 https://medicaex.com/wp-content/uploads/2022/08/image1-F8seLn.jpeg https://medicaex.com/prnewswire/bio-asia-taiwan-2022-concludes-marking-another-successful-edition-of-the-regions-biggest-bioindustry-focused-conference-and-exhibition/ 2022-08-08T02:58:26+00:00 https://medicaex.com/wp-content/uploads/2022/08/BIO_Asia_Taiwan_2022-turqom.jpeg https://medicaex.com/prnewswire/qmed-asia-launches-qmed-go-mini-clinics-to-solve-rising-employee-healthcare-costs/ 2022-08-08T02:58:25+00:00 https://medicaex.com/wp-content/uploads/2022/08/Qmed_Go_copy-R8IFZJ.jpeg https://medicaex.com/prnewswire/united-biopharmas-study-reveals-new-class-of-monoclonal-antibody-for-effective-relief-of-urticaria-symptoms/ 2022-08-08T01:58:33+00:00 https://medicaex.com/prnewswire/epigenic-therapeutics-raises-20-million-in-series-angel-and-pre-a-funding-to-advance-next-generation-gene-editing-therapy/ 2022-08-08T01:58:32+00:00 https://medicaex.com/wp-content/uploads/2022/08/Epigenic_Therapeutics_Logo-KZye6Z.jpeg https://medicaex.com/prnewswire/bioduro-sundia-and-x-chem-enter-partnership-to-launch-del-services-in-china-for-the-discovery-of-new-small-molecule-drugs/ 2022-08-08T01:58:29+00:00 https://medicaex.com/wp-content/uploads/2022/08/BioDuro_Sundia-iPHqQL.jpeg https://medicaex.com/prnewswire/wetrade-group-announced-a-strategic-partnership-with-jiqing-bio-company-to-exclusively-sell-monkeypox-test-kits-and-antigen-tests/ 2022-08-08T01:00:46+00:00 https://medicaex.com/prnewswire/telix-and-university-of-queensland-led-consortium-awarded-5m-australian-research-council-arc-grant/ 2022-08-08T01:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/08/Telix_Logo-uR2Yba.jpeg https://medicaex.com/prnewswire/ascletis-announces-first-patient-dosed-in-the-u-s-phase-i-clinical-trial-of-oral-pd-l1-small-molecule-inhibitor-prodrug-asc61-for-treatment-of-advanced-solid-tumors/ 2022-08-08T01:00:42+00:00 https://medicaex.com/prnewswire/cstone-presents-updated-results-of-a-registrational-study-of-sugemalimab-in-patients-with-stage-iii-nsclc-via-oral-presentation-at-wclc-2022/ 2022-08-08T01:00:42+00:00 https://medicaex.com/prnewswire/111-to-announce-second-quarter-2022-unaudited-financial-results-on-august-25-2022-conference-call-to-follow/ 2022-08-07T23:59:31+00:00 https://medicaex.com/prnewswire/innovent-biologics-and-sanofi-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china/ 2022-08-07T23:59:31+00:00 https://medicaex.com/prnewswire/cgbio-signing-a-north-america-out-license-contract-on-novosis-rhbmp-2-a-bone-substitute-with-orthofix-usa/ 2022-08-07T23:59:31+00:00 https://medicaex.com/wp-content/uploads/2022/08/CGBio_Orthofix_CI_final-JT1ZGK.jpeg https://medicaex.com/prnewswire/the-debut-of-tiangen-received-passionate-feedback-at-aacc-2022/ 2022-08-06T23:00:50+00:00 https://medicaex.com/wp-content/uploads/2022/08/9E5BA2D057BF46A58218DF3A90483BBE_ID_7e17d62d7952-KxrwJ1.jpeg https://medicaex.com/prnewswire/waterdrop-releases-the-2020-21-esg-report-striving-to-provide-high-quality-and-sustainable-protection-to-billions-of-families/ 2022-08-06T23:00:37+00:00 https://medicaex.com/prnewswire/portfolio-highlights-clinical-and-financing-updates-of-aixplorerbio-genhouse-vivavision-domain-amberstone-anji-and-quralis/ 2022-08-05T12:59:43+00:00 https://medicaex.com/prnewswire/profoundbio-receives-fda-study-may-proceed-letter-for-pro1184-a-folate-receptor-alpha-directed-adc-with-a-topoisomerase-1-inhibitor-payload-and-welcomes-naomi-hunder-m-d-as-chief-medical-offi/ 2022-08-05T12:59:35+00:00 https://medicaex.com/prnewswire/fwd-partners-with-klook-for-customers-in-southeast-asia/ 2022-08-05T02:57:53+00:00 https://medicaex.com/wp-content/uploads/2022/08/FWD_logo-A7mmYQ.jpeg https://medicaex.com/prnewswire/nch-asia-pacific-launches-disaster-prevention-program-to-combat-extreme-weather-conditions/ 2022-08-05T01:59:08+00:00 https://medicaex.com/wp-content/uploads/2022/08/NCH-ACOMQX.jpeg https://medicaex.com/prnewswire/mgi-announces-commercial-availability-of-hotmps-sequencing-chemistryand-instrumentin-the-united-kingdom/ 2022-08-04T15:58:59+00:00 https://medicaex.com/prnewswire/evowera-receives-american-dental-association-certificate-for-planck-o1-electric-toothbrush/ 2022-08-04T15:00:03+00:00 https://medicaex.com/wp-content/uploads/2022/08/image_1-lrVVMr.jpeg https://medicaex.com/prnewswire/tikomeds-ilb-activates-the-bodys-natural-repair-signals-to-restore-glutamate-homeostasis-amino-acid-metabolism-and-neurocognitive-functions-in-a-rat-model-of-severe-traumatic-brain-injury/ 2022-08-04T13:59:09+00:00 https://medicaex.com/prnewswire/tceb-and-phuket-welcome-enquiry-mission-members-from-world-expos-governing-body-to-assess-phukets-candidacy-for-expo-2028/ 2022-08-04T11:58:50+00:00 https://medicaex.com/wp-content/uploads/2022/08/BIE_Inspection_Mission_in_Phuket_for_Expo_2028-iAoZP0.jpeg https://medicaex.com/prnewswire/technology-solutions-to-boost-employee-experience-and-improve-patient-outcomes/ 2022-08-04T10:02:59+00:00 https://medicaex.com/prnewswire/yidu-tech-releases-fy2022-esg-report-using-socially-beneficial-technology-to-drive-the-sustainable-development-of-green-healthcare/ 2022-08-04T01:58:02+00:00 https://medicaex.com/prnewswire/ascletis-announces-ind-filing-of-oral-rdrp-inhibitor-asc10-for-covid-19-accepted-by-china-nmpa/ 2022-08-04T00:57:54+00:00 https://medicaex.com/prnewswire/havas-health-you-partners-with-republica-havas-to-create-republica-havas-health/ 2022-08-03T13:58:20+00:00 https://medicaex.com/wp-content/uploads/2022/08/HH_Y_Logo_Logo-DjkSfl.jpeg https://medicaex.com/prnewswire/history-of-hypertensive-disorders-during-pregnancy-linked-to-increased-risk-of-dementia/ 2022-08-03T13:02:01+00:00 https://medicaex.com/wp-content/uploads/2022/08/AAIC_Vascular_Dementia-xLMiWY.jpeg https://medicaex.com/prnewswire/highlights-from-the-alzheimers-association-international-conference-2022/ 2022-08-03T13:02:00+00:00 https://medicaex.com/wp-content/uploads/2022/08/AAIC22_purple_font_rgb_Logo-r89Rxf.jpeg https://medicaex.com/prnewswire/sanyou-biopharmaceuticals-closed-the-series-b-financing-round-of-tens-of-millions-of-rmb-led-by-huatai-zijin/ 2022-08-03T11:58:22+00:00 https://medicaex.com/wp-content/uploads/2022/08/Logo-N42RC3.jpeg https://medicaex.com/prnewswire/antengene-announces-first-patient-dosed-in-the-probe-cn-study-of-atg-101-pd-l1-4-1bb-bispecific-antibody-for-the-treatment-of-solid-tumors-and-non-hodgkin-lymphoma/ 2022-08-03T11:58:21+00:00 https://medicaex.com/wp-content/uploads/2022/08/ANTENGENE_EN_Logo-sRlICw.jpeg https://medicaex.com/prnewswire/lim-chin-hau-and-medicap-sdn-bhd-awarded-at-the-asia-pacific-enterprise-awards-2022-malaysia/ 2022-08-03T11:58:20+00:00 https://medicaex.com/wp-content/uploads/2022/08/Medicap_Sdn_Bhd-Xib0k1.jpeg https://medicaex.com/prnewswire/approval-of-the-comparative-study-between-recov-and-mrna-vaccines-by-fda-in-the-philippines/ 2022-08-03T11:58:20+00:00 https://medicaex.com/wp-content/uploads/2022/08/Recbio_Logo-qsw5tB.jpeg https://medicaex.com/prnewswire/ablaze-pharma-aligned-the-strategic-agreement-with-wenjiang-district-government-of-chengdu-to-build-up-the-innovative-rd-and-manufacturing-center-for-targeted-radiopharmaceutical-therapies/ 2022-08-03T10:58:37+00:00 https://medicaex.com/prnewswire/ascletis-announces-fda-clearance-of-oral-rdrp-inhibitor-asc10-to-conduct-a-randomized-placebo-controlled-phase-ib-study-in-mild-to-moderate-covid-19-patients/ 2022-08-03T09:57:58+00:00 https://medicaex.com/prnewswire/context-therapeutics-and-the-menarini-group-announce-clinical-trial-collaboration-and-supply-agreement-to-evaluate-ona-xr-and-elacestrant-combination/ 2022-08-03T08:58:30+00:00 https://medicaex.com/wp-content/uploads/2022/08/MENARINI_Group_Logo-cvYBAy.jpeg https://medicaex.com/prnewswire/lynk-pharmaceuticals-announces-ind-approval-of-lnk01004-for-atopic-dermatitis-in-china/ 2022-08-03T08:58:18+00:00 https://medicaex.com/prnewswire/sciwind-biosciences-announces-positive-topline-results-from-20-week-phase-2-clinical-trial-of-xw003-ecnoglutide-a-novel-long-lasting-glp-1-analogue-in-adult-patients-with-type-2-diabetes-in-china/ 2022-08-03T08:51:25+00:00 https://medicaex.com/prnewswire/zymo-researchs-dna-rna-shield-inactivates-monkeypox-for-the-collection-and-transportation-of-samples/ 2022-08-03T08:51:15+00:00 https://medicaex.com/wp-content/uploads/2022/08/Zymo_Research_Corp_ITM-dh0OtR.jpeg https://medicaex.com/prnewswire/u-s-cdc-advisory-committee-unanimously-recommends-novavax-covid-19-vaccine-adjuvanted-as-a-primary-series-for-individuals-aged-18-and-older/ 2022-08-03T08:51:14+00:00 https://medicaex.com/wp-content/uploads/2022/08/Novavax_High_Res_Logo-mAO7Xi.jpeg https://medicaex.com/prnewswire/arctic-vision-announces-first-patient-enrolled-in-phase-iii-clinical-trial-of-arvn003-for-presbyopia/ 2022-08-03T08:51:12+00:00 https://medicaex.com/prnewswire/china-cde-grants-breakthrough-therapy-designation-btd-to-neurophths-nr082-in-lhon/ 2022-08-03T08:51:11+00:00 https://medicaex.com/prnewswire/motex-showcases-award-winning-face-masks-in-miami-at-fime-2022/ 2022-08-03T08:51:10+00:00 https://medicaex.com/wp-content/uploads/2022/08/Motex_showcases_award_winning_face_masks_advanced_total_solutions_FIME_2022-6x7yA3.jpeg https://medicaex.com/prnewswire/anti-pd-1-monoclonal-antibody-puyouheng-hx-008-pucotenlimab-injection-co-developed-by-lepu-biopharma-and-hanx-biopharmaceuticals-was-approved-for-marketing-in-china-by-nmpa/ 2022-08-03T08:51:10+00:00 https://medicaex.com/prnewswire/novavax-announces-expanded-approval-of-nuvaxovid-covid-19-vaccine-for-adolescents-aged-12-through-17-in-japan-2/ 2022-08-03T08:51:08+00:00 https://medicaex.com/wp-content/uploads/2022/08/Novavax_High_Res_Logo-Hw1OuD.jpeg https://medicaex.com/prnewswire/novavax-announces-expanded-approval-of-nuvaxovid-covid-19-vaccine-for-adolescents-aged-12-through-17-in-japan/ 2022-08-03T08:51:06+00:00 https://medicaex.com/wp-content/uploads/2022/08/Novavax_High_Res_Logo-DbrpcT.jpeg https://medicaex.com/prnewswire/persistent-loss-of-smell-due-to-covid-19-closely-connected-to-long-lasting-cognitive-problems/ 2022-08-03T08:51:04+00:00 https://medicaex.com/wp-content/uploads/2022/08/AAIC22_purple_font_rgb_Logo-1aG6Xs.jpeg https://medicaex.com/prnewswire/greenlight-biosciences-and-samsung-biologics-complete-first-commercial-scale-engineering-run-for-mrna-covid-19-vaccine/ 2022-08-03T08:51:03+00:00 https://medicaex.com/prnewswire/novel-and-fast-typing-method-developed-to-control-monkeypox-by-molecular-biology-systems-mbs-in-collaboration-with-the-amsterdam-umc-and-danish-rigshospitalet/ 2022-08-03T08:51:03+00:00 https://medicaex.com/prnewswire/ogawa-world-berhad-won-the-asia-pacific-enterprise-awards-2022-malaysia-under-inspirational-brand-category/ 2022-08-03T08:49:15+00:00 https://medicaex.com/wp-content/uploads/2022/08/OGAWA_WORLD_BERHAD-Ne8UWo.jpeg https://medicaex.com/prnewswire/us-fda-awards-rare-pediatric-disease-designation-rpdd-to-paxalisib-for-at-rt-a-rare-form-of-childhood-brain-cancer/ 2022-08-03T08:47:24+00:00 https://medicaex.com/wp-content/uploads/2022/08/Kazia_Logo-9D9eOa.jpeg https://medicaex.com/prnewswire/us-fda-approves-qbiotics-investigational-new-drug-application-to-initiate-tigilanol-tiglate-soft-tissue-sarcoma-phase-ii-trial/ 2022-08-03T08:47:23+00:00 https://medicaex.com/prnewswire/ulab-clear-aligner-platform-is-now-available-in-australia-and-new-zealand/ 2022-08-03T08:46:45+00:00 https://medicaex.com/wp-content/uploads/2022/08/ulab_Logo-ISTYzZ.jpeg https://medicaex.com/prnewswire/edan-launches-next-gen-abg-solutions-for-the-clinic-during-2022-aacc/ 2022-08-03T05:37:57+00:00 https://medicaex.com/prnewswire/nouls-hydrogel-stamping-is-the-potential-core-technology-necessary-for-precise-cancer-diagnosis-study-confirmed/ 2022-08-03T05:37:56+00:00 https://medicaex.com/prnewswire/clarius-applauded-by-frost-sullivan-with-2022-north-american-portable-ultrasound-technology-innovation-leadership-award-for-enabling-high-quality-and-more-affordable-ultrasound-imaging-with-its/ 2022-08-03T05:37:53+00:00 https://medicaex.com/prnewswire/qt-medicals-online-order-mail-delivery-xpress-ecg-testing-service-to-exhibit-at-the-worlds-largest-annual-trade-show/ 2022-08-03T05:37:51+00:00 https://medicaex.com/prnewswire/meihua-international-medical-technologies-co-ltd-reports-2021-financial-year-results/ 2022-08-03T05:37:46+00:00 https://medicaex.com/prnewswire/dr-ivan-puah-recommends-fat-grafting-as-a-solution-following-post-surgery-scars-or-disfigurement/ 2022-08-03T03:05:24+00:00 https://medicaex.com/prnewswire/new-immunotherapy-combination-study-for-nasopharyngeal-cancer-demonstrates-effectiveness-of-lunit-ai-as-predictive-aid-in-treatment-outcome-published-in-clinical-cancer-research/ 2022-08-03T03:05:24+00:00 https://medicaex.com/wp-content/uploads/2022/08/Lunit_SCOPE_IO-cYu6hM.jpeg https://medicaex.com/prnewswire/pharming-group-receives-accelerated-assessment-in-europe-for-leniolisib-for-the-treatment-of-rare-immunodeficiency-apds/ 2022-08-03T03:05:21+00:00 https://medicaex.com/wp-content/uploads/2022/08/Pharming_Group_NV_Logo-jdLudx.jpeg https://medicaex.com/prnewswire/global-fund-reports-significant-progress-in-breaking-down-human-rights-related-barriers-to-hiv-and-tb-services/ 2022-08-03T03:01:37+00:00 https://medicaex.com/wp-content/uploads/2022/08/The_Global_Fund_Logo-86eQnK.jpeg https://medicaex.com/prnewswire/bamf-health-and-telix-complete-first-total-body-pet-scans-with-illuccix-for-prostate-cancer-imaging/ 2022-08-03T03:01:34+00:00 https://medicaex.com/wp-content/uploads/2022/08/Telix_Logo-nClOOZ.jpeg https://medicaex.com/prnewswire/vela-diagnostics-develops-pcr-based-test-for-detecting-monkeypox-virus/ 2022-08-02T10:12:25+00:00